CD4 and prediabetes syndrome: To compare the immunosenescence of T cells in PBMCs from normal controls and patients with prediabetes, we evaluated the frequency of CD57+ and/or CD28− T cells among the CD4+ and CD8+ T cells in the PBMCs from the study population.